Plavix and clinical implications

Genetic variability in response to clopidogrel therapy clinical.

The DDI risk does not exhibit a class effect, eg, the effects of clopidogrel on cerivastatin versus other statins, the effects of proton pump inhibitors on clopidogrel (omeprazole, esomeprazole versus pantoprazole, rabeprazole), the effects of rifampicin on clopidogrel versus ticagrelor and prasugrel, and the effects of calcium channel blockers on clopidogrel (amlodipine versus P-glycoprotein-inhibiting calcium channel blockers).

In what circumstances mht it be advantageous to use ticagrelor.

Prevention of atherothrombotic events Clopidogrel is indicated in: • Adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

<strong>Plavix</strong> - Sanofi Canada

Plavix - Sanofi Canada

Clopidogrel, sold under the brand name Plavix among others, is a medication that is used to reduce the risk of heart disease and stroke in those at hh risk.

American Journal of Gastroenterology - Drug Regulatory Agencies.

From the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (J-r Z, D-q W, JD, G-s Q, J-l D, S-b D, Y-j L, QS); Department of Cardiology, The Dong Nan Hospital, Chongqing, China (J-r Z); and Department of Hematology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China (J-x C).


Plavix and clinical implications:

Rating: 89 / 100

Overall: 99 Rates